News & Updates

Cutting first-day dexamethasone dose not recommended for breast cancer patients on anthracycline
Cutting first-day dexamethasone dose not recommended for breast cancer patients on anthracycline
11 Dec 2021

In breast cancer patients treated with anthracycline-containing regimens, reducing the first-day dose of dexamethasone does not yield significant gastrointestinal benefit and is not recommended for nausea management, a recent study has found.

Cutting first-day dexamethasone dose not recommended for breast cancer patients on anthracycline
11 Dec 2021
Alcohol abstinence lowers HCC risk in patients with cirrhosis
Alcohol abstinence lowers HCC risk in patients with cirrhosis
10 Dec 2021

Abstinence from alcoholic drinks reduces the risk of hepatocellular carcinoma (HCC) in patients with alcohol-related liver cirrhosis, but not in those with a history of decompensated disease, reveals a study.

Alcohol abstinence lowers HCC risk in patients with cirrhosis
10 Dec 2021
Breast cancer: Dense breasts may spell trouble for menopausal women
Breast cancer: Dense breasts may spell trouble for menopausal women
08 Dec 2021